Treatment of post-psychotic depression in first-episode psychosis. A systematic review

References

• Koreen AR, Siris SG, Chakos M, et al. Depression in first-episode schizophrenia. Am J Psychiatry. 1993;150(11):1643–1648. PMID: 8105706.
   PubMed Web of Science ®Google Scholar
• Häfner H, Maurer K, Trendler G, et al. Schizophrenia and depression: Challenging the paradigm of two separate diseases-a controlled study of schizophrenia, depression and healthy controls. Schizophr Res. 2005;77(1):11–24.
   PubMed Web of Science ®Google Scholar
• Upthegrove R, Birchwood M, Ross K, et al. The evolution of depression and suicidality in first episode psychosis. Acta Psychiatr Scand. 2010;122(3):211–218.
   PubMed Web of Science ®Google Scholar
• Kraepelin E. Dementia praecox and paraphrenia.  Zschr Ges Neurol Psychiat 1920;62:1–29.
   Google Scholar
• Bleuler M, Bleuler R. Dementia praecox oder die gruppe der schizophrenien: Eugen bleuler. Br J Psychiatry. 1986;149(5):661–664.
   PubMedGoogle Scholar
• World Health Organization(WHO). The ICD-10 classification of mental and behavioural disorders. 1993.
   Google Scholar
• American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed., text rev.) 2000.
   Google Scholar
• American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders (5th ed.). American Journal of Psychiatry. 2013.
   Google Scholar
• Bressan RA, Costa DC, Jones HM, et al. Typical antipsychotic drugs - D2 receptor occupancy and depressive symptoms in schizophrenia. Schizophr Res. 2002;56(1-2):31–36.
   PubMed Web of Science ®Google Scholar
• Fitzgerald PB, Rolfe TJ, Brewer K, et al. Depressive, positive, negative and parkinsonian symptomsin schizophrenia. Aust N Z J Psychiatry. 2002;36(3):340–346.
   PubMed Web of Science ®Google Scholar
• Bartels SJ, Drake RE. Depressive symptoms in schizophrenia: Comprehensive differential diagnosis. Compr Psychiatry. 1988;29(5):467–483.
   PubMed Web of Science ®Google Scholar
• Birchwood M, Iqbal Z, Chadwick P, et al. Cognitive approach to depression and suicidal thinking in psychosis. 1. Ontogeny of post-psychotic depression. Br J Psychiatry. 2000;177:516–521.
   PubMed Web of Science ®Google Scholar
• Corrigan PW. How clinical diagnosis might exacerbate the stigma of mental illness. Soc Work. 2007;52(1):31–39.
   PubMed Web of Science ®Google Scholar
• Upthegrove R, Ross K, Brunet K, et al. Depression in first episode psychosis: the role of subordination and shame. Psychiatry Res. 2014;217(3):177–184.
   PubMed Web of Science ®Google Scholar
• Birchwood M, Iqbal Z, Upthegrove R. Psychological pathways to depression in schizophrenia: Studies in acute psychosis, post psychotic depression and auditory hallucinations. Eur Arch Psychiatry Clin Neurosci. 2005;255(3):202–212.
   PubMed Web of Science ®Google Scholar
• Barrett EA, Mork E, Faerden A, et al. The development of insight and its relationship with suicidality over one year follow-up in patients with first episode psychosis. Schizophr Res. 2015;162(1-3):97–102.
   PubMed Web of Science ®Google Scholar
• McGinty J, Sayeed Haque M, Upthegrove R. Depression during first episode psychosis and subsequent suicide risk: a systematic review and Meta-analysis of longitudinal studies. Schizophr Res. 2018;195:58–66.
   PubMed Web of Science ®Google Scholar
• Oosthuizen P, Emsley R, Niehaus D, et al. The relationships between depression and remission in first-episode psychosis. World Psychiatry. 2006;5(3):172–176.
   PubMed Web of Science ®Google Scholar
• Sandhu A, Ives J, Birchwood M, et al. The subjective experience and phenomenology of depression following first episode psychosis: a qualitative study using photo-elicitation. J Affect Disord. 2013;149(1-3):166–174.
   PubMed Web of Science ®Google Scholar
• Austin SF, Mors O, Budtz-Jørgensen E, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10year follow-up study in the OPUS cohort. Schizophr Res. 2015;168(1-2):84–91..
   PubMed Web of Science ®Google Scholar
• Ayesa-Arriola R, Alcaraz EG, Hernández BV, et al. Suicidal behaviour in first-episode non-affective psychosis: Specific risk periods and stage-related factors. Eur Neuropsychopharmacol. 2015;25(12):2278–2288.
   PubMed Web of Science ®Google Scholar
• Harvey SB, Dean K, Morgan C, et al. Self-harm in first-episode psychosis. Br J Psychiatry. 2008;192(3):178–184.
   PubMed Web of Science ®Google Scholar
• Reading B, Birchwood M. Early intervention in psychosis: Rationale and evidence for effectiveness. Dis Manag Heal Outcomes. 2005;13(1):53–63.
   Google Scholar
• Kohler CG, Lallart EA. Postpsychotic depression in schizophrenia patients. Curr Psychiatry Rep. 2002;4(4):273–278. http://www.psy-paris-75015.fr/library/images/kohler-lallart-nova2004.pdf
   PubMedGoogle Scholar
• Page MJ, McKenzie JE, Bossuyt PM, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
   PubMed Web of Science ®Google Scholar
• Overall JE, Gorham DR. The brief psychiatric rating scale. Psychol Rep. 1962;10(3):799–812.
   Web of Science ®Google Scholar
• Addington D, Addington J, Maticka-Tyndale E. Assessing depression in schizophrenia: the calgary depression scale. Br J Psychiatry. 1993;163(S22):39–44.
   Web of Science ®Google Scholar
• Hamilton MA. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960;23(1):56–62..
   PubMed Web of Science ®Google Scholar
• Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382–389..
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Isaacs I, Fuchs C, et al. Attenuation of Olanzapine-Induced weight gain with reboxetine in patients with schizophrenia. Am J Psychiatry. 2003;160(2):297–302.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Fuchs C, Pashinian A, et al. Attenuating effect of reboxetine on appetite and weight gain in olanzapine-treated schizophrenia patients: a double-blind placebo-controlled study. Psychopharmacology. 2007;192(3):441–448.
   PubMed Web of Science ®Google Scholar
• Poyurovsky M, Pashinian A, Gil-Ad I, et al. Olanzapine-induced weight gain in patients with first-episode schizophrenia: a double-blind, placebo-controlled study of fluoxetine addition. Am J Psychiatry. 2002;159(6):1058–1060.
   PubMed Web of Science ®Google Scholar
• Bobes J, Gibert J, Ciudad A, et al. Safety and effectiveness of olanzapine versus conventional antipsychotics in the acute treatment of first-episode schizophrenic inpatients. Prog Neuro-Psychopharmacology Biol Psychiatry. 2003;27(3):473–481.
   PubMed Web of Science ®Google Scholar
• Crespo-Facorro B, Pérez-Iglesias R, Mata I, et al. Aripiprazole, ziprasidone, and quetiapine in the treatment of first-episode nonaffective psychosis: Results of a 6-week, randomized, flexible-dose, open-label comparison. J Clin Psychopharmacol. 2013;33(2):215–220.
   PubMed Web of Science ®Google Scholar
• Lieberman JA, Tollefson G, Tohen M, HGDH Study Group, et al. Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol. Am J Psychiatry. 2003;160(8):1396–1404.
   PubMed Web of Science ®Google Scholar
• McEvoy JP, Lieberman JA, Perkins DO, et al. Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison. Am J Psychiatry. 2007;164(7):1050–1060.
   PubMed Web of Science ®Google Scholar
• Riedel M, Mayr A, Seemüller F, et al. Depressive symptoms and their association with acute treatment outcome in first-episode schizophrenia patients: Comparing treatment with risperidone and haloperidol. World J Biol Psychiatry. 2012;13(1):30–38.
   PubMed Web of Science ®Google Scholar
• Robinson DG, Gallego JA, John M, et al. A randomized comparison of aripiprazole and risperidone for the acute treatment of First-Episode schizophrenia and related disorders: 3-Month outcomes. Schizophr Bull. 2015;41(6):1227–1236.
   PubMed Web of Science ®Google Scholar
• Rybakowski JK, Vansteelandt K, Szafranski T, EUFEST Study Group, et al. Treatment of depression in first episode of schizophrenia: Results from EUFEST. Eur Neuropsychopharmacol. 2012;22(12):875–882.
   PubMed Web of Science ®Google Scholar
• Takahashi H, Yoshida K, Ishigooka J, et al. Switching to risperidone after unsuccessful treatment of olanzapine in the first-episode schizophrenia: an open trial. Prog Neuro-Psychopharmacology Biol Psychiatry. 2006;30(6):1067–1072.
   PubMed Web of Science ®Google Scholar
• Zabala A, Bustillo M, Querejeta I, et al. A pilot study of the usefulness of a single olanzapine plasma concentration as an indicator of early drug effect in a small sample of First-Episode psychosis patients. J Clin Psychopharmacol. 2017;37(5):569–577.
   PubMed Web of Science ®Google Scholar
• Zhao T, Park TW, Yang JC, et al. Efficacy and safety of ziprasidone in the treatment of first-episode psychosis: an 8-week, open-label, multicenter trial. Int Clin Psychopharmacol. 2012;27(4):184–190.
   PubMed Web of Science ®Google Scholar
• Goff DC, Freudenreich O, Cather C, et al. Citalopram in first episode schizophrenia: the DECIFER trial. Schizophr Res. 2019;208:331–337.
   PubMed Web of Science ®Google Scholar
• Alvarez-Jimenez M, Bendall S, Koval P, et al. HORYZONS trial: Protocol for a randomised controlled trial of a moderated online social therapy to maintain treatment effects from first-episode psychosis services. BMJ Open. 2019;9(2):e024104.
   PubMedGoogle Scholar
• Gaynor K, Dooley B, Lawlor E, et al. Group cognitive behavioural therapy as a treatment for negative symptoms in first-episode psychosis. Early Interv Psychiatry. 2011;5(2):168–173.
   PubMed Web of Science ®Google Scholar
• Jackson C, Trower P, Reid I, et al. Improving psychological adjustment following a first episode of psychosis: a randomised controlled trial of cognitive therapy to reduce post psychotic trauma symptoms. Behav Res Ther. 2009;47(6):454–462.
   PubMed Web of Science ®Google Scholar
• Mendella PD, Burton CZ, Tasca GA, et al. Compensatory cognitive training for people with first-episode schizophrenia: Results from a pilot randomized controlled trial. Schizophr Res. 2015;162(1-3):108–111.
   PubMed Web of Science ®Google Scholar
• Jackson H, McGorry P, Edwards J, et al. Cognitively-oriented psychotherapy for early psychosis (COPE): preliminary results. Br J Psychiatry. 1998;172(S33):93–100.
   Google Scholar
• Alvarez-Jimenez M, Bendall S, Lederman R, et al. On the HORYZON: moderated online social therapy for long-term recovery in first episode psychosis. Schizophr Res. 2013;143(1):143–149.
   PubMed Web of Science ®Google Scholar
• Campbell IM, Shaw CA, Stankiewicz P, et al. Somatic mosaicism: implications for disease and transmission genetics. Trends Genet. 2015;31(7):382–392.
   PubMed Web of Science ®Google Scholar
•  Pawełczyk T, Grancow M, Kotlicka-Antczak M, Trafalska E, Gȩbski P, Szemraj J, … Pawełczyk A. Omega-3 fatty acids in first-episode schizophrenia - A randomized controlled study of efficacy and relapse prevention (OFFER): Rationale, design, and methods. BMC Psychiatry, 2015;15(1):1–13. https://doi.org/10.1186/s12888-015-0473-2
   Google Scholar